Noninvasive quantitative imaging-based biomarkers and lung cancer screening

American Journal of Respiratory and Critical Care Medicine

Volumn 192, Issue 6, 2015, Pages 654-656

  Schabath, Matthew B ^a   Gillies, Robert J ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NODULE; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SMOKING; THORAX RADIOGRAPHY; UNITED STATES; ADENOCARCINOMA; CLINICAL DECISION MAKING; COMPUTER ASSISTED DIAGNOSIS; DECISION SUPPORT SYSTEM; EARLY DIAGNOSIS; FEMALE; LUNG TUMOR; MALE; PROCEDURES; RADIOGRAPHY;

ADENOCARCINOMA; CLINICAL DECISION-MAKING; DECISION SUPPORT TECHNIQUES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84942258617     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201506-1160ED     Document Type: Editorial

References (18)

1. American Cancer Society. Cancer facts & figures 2015. Atlanta: American Cancer Society; 2015.
2. American Cancer Society. Global cancer facts & figures, 2nd ed. Atlanta: American Cancer Society; 2011.
3. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
4. U.S. Preventive Services Task Force. Final recommendation statement: lung cancer: screening. Rockville, MD: U.S. Preventive Services Task Force; 2013 [accessed 2015 Jun 2]. Available at: http://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/lung-cancer-screening
5. Centers for Medicare & Medicaid Services. Decision memo for screening for lung cancer with low dose computed tomography (LDCT) (CAG-00439N). Baltimore, MD: Centers for Medicare & Medicaid Services [accessed 2015 Jun 2]. Available from: http://www.cms.gov/medicarecoverage-database/details/nca-decision-memo.aspx?NCAId=274&NcaName=Screening1for1Lung1Cancer1with1Low1Dose1Computed1Tomography1(LDCT)&TimeFrame=7&DocType=All&bc=AQAAIAAAAgAAAA%3d%3d&
6. Manser R, Lethaby A, Irving LB, Stone C, Byrnes G, Abramson MJ, Campbell D. Screening for lung cancer. Cochrane Database Syst Rev 2013;6:CD001991.
7. Patz EF Jr, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammemägi MC, Chiles C, Black WC, Aberle DR; NLST Overdiagnosis Manuscript Writing Team. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med 2014;174: 269-274.
8. Hassanein M, Callison JC, Callaway-Lane C, Aldrich MC, Grogan EL, Massion PP. The state of molecular biomarkers for the early detection of lung cancer. Cancer Prev Res (Phila) 2012;5:992-1006.
9. Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RG, Granton P, Zegers CM, Gillies R, Boellard R, Dekker A, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 2012;48:441-446.
10. Maldonado F, Duan F, Raghunath SM, Rajagopalan S, Karwoski RA, Garg K, Greco E, Nath H, Robb RA, Bartholmai BJ, et al. Noninvasive computed tomography-based risk stratification of lung adenocarcinomas in the National Lung Screening Trial. Am J Respir Crit Care Med 2015;192:737-744.
11. Maldonado F, Boland JM, Raghunath S, Aubry MC, Bartholmai BJ, Deandrade M, Hartman TE, Karwoski RA, Rajagopalan S, Sykes AM, et al. Noninvasive characterization of the histopathologic features of pulmonary nodules of the lung adenocarcinoma spectrum using computer-aided nodule assessment and risk yield (CANARY): a pilot study. J Thorac Oncol 2013;8:452-460.
12. Padda SK, Burt BM, Trakul N, Wakelee HA. Early-stage non-small cell lung cancer: surgery, stereotactic radiosurgery, and individualized adjuvant therapy. Semin Oncol 2014;41:40-56.
13. Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC. Treatment of stage I and II non-small cell lung cancer. Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:e278S-e313S.
14. Memorial Sloan Kettering Cancer Center. Lung cancer screening decision tool. New York: Memorial Sloan Kettering Cancer Center; 2014 [accessed 2015 Jun 12]. Available from: http://nomograms. mskcc.org/Lung/Screening.aspx
15. Kovalchik SA, Tammemagi M, Berg CD, Caporaso NE, Riley TL, Korch M, Silvestri GA, Chaturvedi AK, Katki HA. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 2013;369:245-254.
16. Kumar V, Gu Y, Basu S, Berglund A, Eschrich SA, Schabath MB, Forster K, Aerts HJ, Dekker A, Fenstermacher D, et al. Radiomics: the process and the challenges. Magn Reson Imaging 2012;30:1234-1248.
17. Centers for Disease Control and Prevention. Cigarette smoking among adults: United States, 2006. MMWR Morb Mortal Wkly Rep 2007; 56:1157-1161.
18. Jamal A, Agaku IT, O'Connor E, King BA, Kenemer JB, Neff L; Centers for Disease Control and Prevention. Current cigarette smoking among adults: United States, 2005-2013. MMWR Morb Mortal Wkly Rep 2014;63:1108-1112.